[Pneumocystis pneumonia in a renal transplant recipient].

Abstract

Pneumocystis pneumonia (PCP) is an opportunistic infection caused by Pneumocystis jirovecii (P. jirovecii) in humans. We reported a 23 year-old male patient who developed pneumonia after renal transplantation. P. jirovecii cysts and trophozoites were detected in bronchoalveolar lavage (BAL) samples of the patient by Giemsa, methenamine-silver and Toluidine-O staining. The patient, who was diagnosed as PCP, was discharged as he recovered by 21 days trimethoprim-sulfamethoxazole (TMP-SMX) therapy. This case, who developed PCP even though he had received prophylaxis after transplantation, was reported to emphasize the importance of the agent in immunocompromised patients.

• Authors: Soykan Özkoç, Tonay İnceboz, Aykut Sıfıl, Sema Tuncay, Çiler Akisü
• Journal: Turkiye parazitolojii dergisi (Turkiye Parazitol Derg) Vol. 34 Issue 4 Pg. 186-9 ( 2010) ISSN: 2146-3077 [Electronic] Turkey
• Vernacular Title: Böbrek transplantasyonlu bir hastada Pneumocystis pnömonisi.
• PMID: 21391190 (Publication Type: Case Reports, Journal Article)

Chemical References

• Anti-Infective Agents
• Trimethoprim, Sulfamethoxazole Drug Combination

Topics

• Anti-Infective Agents (therapeutic use)
• Bronchoalveolar Lavage Fluid (parasitology)
• Humans
• Immunocompromised Host
• Kidney Transplantation
• Male
• Opportunistic Infections (drug therapy, etiology, parasitology)
• Pneumocystis carinii (isolation & purification)
• Pneumonia, Pneumocystis (drug therapy, etiology, parasitology)
• Trimethoprim, Sulfamethoxazole Drug Combination (therapeutic use)
• Young Adult